[ad_1] Image source: Getty Images The Santa Rally of early December now seems a long, long time ago. Today, stock markets are awash with a sea of red, with some predicting that a US stock market crash could be around…
[ad_1] Paychex Inc. (NASDAQ: PAYX) on Thursday reported an increase in revenues and earnings for the second quarter of 2025. Earnings also came in above analysts’ forecasts. Revenues of the Rochester-based human capital management solutions provider grew by 5% and reached…
[ad_1] Image source: Getty Images Lately I’ve been exercising my brain over which companies to buy for my Stocks and Shares ISA next year – but am I guilty of overthinking it? These two FTSE 100 stalwarts look so solid…
[ad_1] Accenture (NYSE: ACN) reported its first quarter 2025 earnings results today. Revenues were $17.7 billion, up 9% in US dollars and 8% in local currency compared to the same period a year ago. Net income attributable to Accenture Plc…
[ad_1] Image source: Getty Images The Scottish Mortgage (LSE: SMT) share price has lit up my portfolio, jumping almost 20% in the last three months. The Baillie Gifford-managed investment trust is up 21.94% over the last year, as it continues to…
[ad_1] Image source: Getty Images The steady returns and growth potential that dividend stocks offer make them highly attractive for a second income. Whether to supplement a salary or build towards a retirement fund, they’re a key part of most…
[ad_1] Image source: Getty Images The Legal & General (LSE: LGEN) share price looks too low to me, judging by those headline figures. They’re based on forecasts for 2025. But even the current 2024 outlook suggests a 9.4% dividend yield…
[ad_1] Image source: Getty Images HSBC (LSE: HSBA) shares are a key holding in my passive income portfolio, comprised of high-yield stocks. I aim to increasingly live off the dividends they pay and reduce my working commitments. I have built…
[ad_1] Image source: Getty Images Having some portfolio exposure to S&P 500 stocks has really paid off this year. Over in the US, a lot of stocks have soared in 2024. In 2025, it’s highly likely that the US stock…
[ad_1] Gelteq Limited (NASDAQ: GELS) is a healthcare company specializing in the development and manufacturing of edible gel products, with a focus on areas like pharmaceuticals, nutraceuticals, pet care, and sports nutrition. The company’s gel-based oral drug delivery system is…